Lilly and Incyte Provide Update on Baricitinib
Go back to Lilly and Incyte Provide Update on Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 95.94 -1.39 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.33 | 52 Week High | $118.49 | |||
| Open | $96.23 | 52 Week Low | $55.00 | |||
| Day High | $96.30 | P/E | N/A | |||
| Day Low | $94.61 | EPS | $-0.56 | |||
| Volume | 1,255,015 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 990.33 +7.07 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $983.26 | 52 Week High | $88.16 | |||
| Open | $975.00 | 52 Week Low | $67.88 | |||
| Day High | $991.22 | P/E | 229.24 | |||
| Day Low | $966.09 | EPS | $4.32 | |||
| Volume | 2,627,108 | |||||
